

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.74770953 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.74770953 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.37272863 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.37272863 |
| 5 | exogenous drug catabolic process (GO:0042738) | 7.21088650 |
| 6 | drug catabolic process (GO:0042737) | 6.87444422 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.55210438 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.09800883 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 5.85414183 |
| 10 | fibrinolysis (GO:0042730) | 5.20314094 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.09746854 |
| 12 | bile acid biosynthetic process (GO:0006699) | 4.95826184 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.72468201 |
| 14 | cysteine metabolic process (GO:0006534) | 4.66385886 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.64195613 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.64105044 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.64105044 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.64105044 |
| 19 | oxidative demethylation (GO:0070989) | 4.61916267 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.56201300 |
| 21 | aromatic amino acid family metabolic process (GO:0009072) | 4.53678753 |
| 22 | kynurenine metabolic process (GO:0070189) | 4.44978627 |
| 23 | ethanol metabolic process (GO:0006067) | 4.42278101 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.38395628 |
| 25 | tyrosine metabolic process (GO:0006570) | 4.37999608 |
| 26 | fatty acid elongation (GO:0030497) | 4.32241820 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.24483749 |
| 28 | bile acid metabolic process (GO:0008206) | 4.23737836 |
| 29 | negative regulation of blood coagulation (GO:0030195) | 4.22325491 |
| 30 | negative regulation of hemostasis (GO:1900047) | 4.22325491 |
| 31 | protein carboxylation (GO:0018214) | 4.14429235 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.14429235 |
| 33 | coenzyme catabolic process (GO:0009109) | 4.12828989 |
| 34 | negative regulation of cholesterol transport (GO:0032375) | 4.10220631 |
| 35 | negative regulation of sterol transport (GO:0032372) | 4.10220631 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 4.08746003 |
| 37 | serine family amino acid biosynthetic process (GO:0009070) | 4.08236470 |
| 38 | flavonoid metabolic process (GO:0009812) | 4.05254697 |
| 39 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.00252513 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 3.98374995 |
| 41 | aldehyde catabolic process (GO:0046185) | 3.96308321 |
| 42 | phenylpropanoid metabolic process (GO:0009698) | 3.94656581 |
| 43 | negative regulation of coagulation (GO:0050819) | 3.92629705 |
| 44 | regulation of plasminogen activation (GO:0010755) | 3.92221142 |
| 45 | daunorubicin metabolic process (GO:0044597) | 3.86524634 |
| 46 | polyketide metabolic process (GO:0030638) | 3.86524634 |
| 47 | doxorubicin metabolic process (GO:0044598) | 3.86524634 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.85213333 |
| 49 | regulation of fibrinolysis (GO:0051917) | 3.84329983 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 3.83619197 |
| 51 | serine family amino acid metabolic process (GO:0009069) | 3.81180201 |
| 52 | cellular amino acid catabolic process (GO:0009063) | 3.80011079 |
| 53 | very long-chain fatty acid metabolic process (GO:0000038) | 3.77464288 |
| 54 | protein activation cascade (GO:0072376) | 3.74443076 |
| 55 | regulation of protein activation cascade (GO:2000257) | 3.72158456 |
| 56 | L-serine metabolic process (GO:0006563) | 3.72050901 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 3.70465922 |
| 58 | glycine metabolic process (GO:0006544) | 3.70235511 |
| 59 | heme transport (GO:0015886) | 3.70198696 |
| 60 | lysine catabolic process (GO:0006554) | 3.69712432 |
| 61 | lysine metabolic process (GO:0006553) | 3.69712432 |
| 62 | urea metabolic process (GO:0019627) | 3.68831523 |
| 63 | urea cycle (GO:0000050) | 3.68831523 |
| 64 | regulation of cholesterol esterification (GO:0010872) | 3.68748510 |
| 65 | complement activation, alternative pathway (GO:0006957) | 3.68626238 |
| 66 | cofactor catabolic process (GO:0051187) | 3.68308700 |
| 67 | short-chain fatty acid metabolic process (GO:0046459) | 3.63625704 |
| 68 | triglyceride homeostasis (GO:0070328) | 3.63433058 |
| 69 | acylglycerol homeostasis (GO:0055090) | 3.63433058 |
| 70 | negative regulation of wound healing (GO:0061045) | 3.61836112 |
| 71 | regulation of triglyceride catabolic process (GO:0010896) | 3.61087599 |
| 72 | ethanol oxidation (GO:0006069) | 3.58483908 |
| 73 | amine catabolic process (GO:0009310) | 3.57579538 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 3.57579538 |
| 75 | response to nitrosative stress (GO:0051409) | 3.55754339 |
| 76 | cellular glucuronidation (GO:0052695) | 3.55203668 |
| 77 | homocysteine metabolic process (GO:0050667) | 3.55125787 |
| 78 | fatty acid beta-oxidation (GO:0006635) | 3.54723405 |
| 79 | S-adenosylmethionine metabolic process (GO:0046500) | 3.53568852 |
| 80 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.52239958 |
| 81 | organic acid catabolic process (GO:0016054) | 3.52001111 |
| 82 | carboxylic acid catabolic process (GO:0046395) | 3.52001111 |
| 83 | xenobiotic catabolic process (GO:0042178) | 3.51967584 |
| 84 | aspartate family amino acid catabolic process (GO:0009068) | 3.51588774 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 3.50902424 |
| 86 | arginine metabolic process (GO:0006525) | 3.50691397 |
| 87 | drug transmembrane transport (GO:0006855) | 3.50220699 |
| 88 | imidazole-containing compound metabolic process (GO:0052803) | 3.50129395 |
| 89 | reverse cholesterol transport (GO:0043691) | 3.49587377 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 3.49526071 |
| 91 | nitrogen cycle metabolic process (GO:0071941) | 3.49200367 |
| 92 | indolalkylamine metabolic process (GO:0006586) | 3.49098795 |
| 93 | branched-chain amino acid catabolic process (GO:0009083) | 3.47111388 |
| 94 | regulation of complement activation (GO:0030449) | 3.47095221 |
| 95 | fatty acid catabolic process (GO:0009062) | 3.46629299 |
| 96 | complement activation (GO:0006956) | 3.46176491 |
| 97 | alkaloid metabolic process (GO:0009820) | 3.45495965 |
| 98 | intestinal cholesterol absorption (GO:0030299) | 3.45374924 |
| 99 | complement activation, classical pathway (GO:0006958) | 3.44825694 |
| 100 | plasma lipoprotein particle remodeling (GO:0034369) | 3.43358507 |
| 101 | protein-lipid complex remodeling (GO:0034368) | 3.43358507 |
| 102 | macromolecular complex remodeling (GO:0034367) | 3.43358507 |
| 103 | fatty acid oxidation (GO:0019395) | 3.41804813 |
| 104 | monocarboxylic acid catabolic process (GO:0072329) | 3.39900509 |
| 105 | primary alcohol catabolic process (GO:0034310) | 3.39258403 |
| 106 | regulation of cholesterol metabolic process (GO:0090181) | 3.39154137 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.39005588 |
| 108 | NADH metabolic process (GO:0006734) | 3.37811668 |
| 109 | benzene-containing compound metabolic process (GO:0042537) | 3.37223020 |
| 110 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.36976823 |
| 111 | phospholipid efflux (GO:0033700) | 3.36805328 |
| 112 | negative regulation of protein activation cascade (GO:2000258) | 3.36778257 |
| 113 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.36090859 |
| 114 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.36058198 |
| 115 | blood coagulation, intrinsic pathway (GO:0007597) | 3.34534718 |
| 116 | glutamate metabolic process (GO:0006536) | 3.34233861 |
| 117 | positive regulation of hemostasis (GO:1900048) | 3.33290808 |
| 118 | positive regulation of blood coagulation (GO:0030194) | 3.33290808 |
| 119 | lipid oxidation (GO:0034440) | 3.33157688 |
| 120 | bile acid and bile salt transport (GO:0015721) | 3.29590404 |
| 121 | xenobiotic metabolic process (GO:0006805) | 3.29144642 |
| 122 | glucuronate metabolic process (GO:0019585) | 3.27572517 |
| 123 | uronic acid metabolic process (GO:0006063) | 3.27572517 |
| 124 | acute-phase response (GO:0006953) | 3.26644031 |
| 125 | axon ensheathment in central nervous system (GO:0032291) | 3.21243066 |
| 126 | central nervous system myelination (GO:0022010) | 3.21243066 |
| 127 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.20868956 |
| 128 | acetyl-CoA metabolic process (GO:0006084) | 3.20793626 |
| 129 | branched-chain amino acid metabolic process (GO:0009081) | 3.19811689 |
| 130 | signal peptide processing (GO:0006465) | 3.19434418 |
| 131 | drug metabolic process (GO:0017144) | 3.18618950 |
| 132 | plasma lipoprotein particle clearance (GO:0034381) | 3.17355915 |
| 133 | cholesterol efflux (GO:0033344) | 3.15609984 |
| 134 | acyl-CoA metabolic process (GO:0006637) | 3.13691974 |
| 135 | thioester metabolic process (GO:0035383) | 3.13691974 |
| 136 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.13306119 |
| 137 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.13306119 |
| 138 | positive regulation of coagulation (GO:0050820) | 3.11859410 |
| 139 | response to mercury ion (GO:0046689) | 3.08990761 |
| 140 | hormone catabolic process (GO:0042447) | 3.00926002 |
| 141 | regulation of humoral immune response (GO:0002920) | 2.99439958 |
| 142 | low-density lipoprotein particle remodeling (GO:0034374) | 2.96908380 |
| 143 | negative regulation of complement activation (GO:0045916) | 2.93643932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.20635177 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.56021317 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.70066904 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.57225370 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.95703787 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.82980585 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.19523458 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.14035776 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.58941542 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.60278303 |
| 11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.59590504 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.36981508 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.31669119 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.15850963 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10457150 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09056639 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99574697 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.97450823 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.95620434 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92269067 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.85611651 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.79378880 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77409247 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71522406 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.71322015 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69407032 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68851168 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63328322 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57974508 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.56554789 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52225070 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50941666 |
| 33 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.45192812 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.40982996 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39952195 |
| 36 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.39577468 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36948795 |
| 38 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.33790754 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27164839 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27098617 |
| 41 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.26733924 |
| 42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23998554 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22611341 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21383465 |
| 45 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.20430055 |
| 46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19446853 |
| 47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16728042 |
| 48 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.16139138 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15357754 |
| 50 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.14927302 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13377984 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12367404 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10179947 |
| 54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09855321 |
| 55 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08915442 |
| 56 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08300468 |
| 57 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06744302 |
| 58 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.05230395 |
| 59 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.04605291 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04185318 |
| 61 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02460350 |
| 62 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02399597 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01901975 |
| 64 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01727967 |
| 65 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98767007 |
| 66 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.98665977 |
| 67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98572611 |
| 68 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97660758 |
| 69 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96623255 |
| 70 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.96551014 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.96521009 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96235596 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95098270 |
| 74 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94944113 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92093280 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91640696 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91518615 |
| 78 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91322353 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90735527 |
| 80 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90683470 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90191120 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90178241 |
| 83 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90107597 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89842638 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89681273 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89443731 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89307455 |
| 88 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89181888 |
| 89 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.87834445 |
| 90 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.87805837 |
| 91 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86683062 |
| 92 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.86486971 |
| 93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85270276 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84592144 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84101547 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84101547 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84025344 |
| 98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83804388 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83730512 |
| 100 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83448033 |
| 101 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.83389781 |
| 102 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82753283 |
| 103 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82620144 |
| 104 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82213088 |
| 105 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.82212016 |
| 106 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82053599 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81599398 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80649236 |
| 109 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.80373398 |
| 110 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.79808479 |
| 111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79554362 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79402202 |
| 113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78375431 |
| 114 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.77582817 |
| 115 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.77550416 |
| 116 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77388975 |
| 117 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77177517 |
| 118 | P300_27268052_Chip-Seq_Bcells_Human | 0.77059969 |
| 119 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.76882992 |
| 120 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76779387 |
| 121 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.76747558 |
| 122 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.76184594 |
| 123 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76047164 |
| 124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75510063 |
| 125 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.75267265 |
| 126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75215438 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.74749038 |
| 128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.74749038 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74239792 |
| 130 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.73991874 |
| 131 | CJUN_26792858_Chip-Seq_BT549_Human | 0.73970583 |
| 132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.73520596 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.73520596 |
| 134 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72934743 |
| 135 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.72658232 |
| 136 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72653258 |
| 137 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.72395317 |
| 138 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.72250238 |
| 139 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.71928689 |
| 140 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71851372 |
| 141 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.71109140 |
| 142 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.70639694 |
| 143 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.70023506 |
| 144 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.69881069 |
| 145 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67832674 |
| 146 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67524559 |
| 147 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.66736373 |
| 148 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65698046 |
| 149 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65399624 |
| 150 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65052005 |
| 151 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65014474 |
| 152 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.63209287 |
| 153 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.63177860 |
| 154 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.60232803 |
| 155 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.59619053 |
| 156 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59455843 |
| 157 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.59351317 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59216040 |
| 159 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.58374427 |
| 160 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.58065523 |
| 161 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57864960 |
| 162 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.57857138 |
| 163 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.57710613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.15048107 |
| 2 | MP0005360_urolithiasis | 5.74663148 |
| 3 | MP0005365_abnormal_bile_salt | 5.67569407 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.31954193 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 5.27511597 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.61159155 |
| 7 | MP0003195_calcinosis | 4.17157899 |
| 8 | MP0009840_abnormal_foam_cell | 3.17422660 |
| 9 | MP0005083_abnormal_biliary_tract | 3.07057009 |
| 10 | MP0003252_abnormal_bile_duct | 3.04599498 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.78857575 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.77961956 |
| 13 | MP0005332_abnormal_amino_acid | 2.71293051 |
| 14 | MP0004043_abnormal_pH_regulation | 2.18106252 |
| 15 | MP0003186_abnormal_redox_activity | 2.13138966 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.08249469 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 1.99004331 |
| 18 | MP0003868_abnormal_feces_composition | 1.97466007 |
| 19 | MP0001764_abnormal_homeostasis | 1.92889914 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.91192683 |
| 21 | MP0000609_abnormal_liver_physiology | 1.88339321 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.81114236 |
| 23 | MP0005220_abnormal_exocrine_pancreas | 1.77332868 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.75091403 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.68219665 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.61353701 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58862275 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.50557775 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.49113136 |
| 30 | MP0005451_abnormal_body_composition | 1.43899649 |
| 31 | MP0005636_abnormal_mineral_homeostasis | 1.40624641 |
| 32 | MP0005408_hypopigmentation | 1.32920124 |
| 33 | MP0000920_abnormal_myelination | 1.29068191 |
| 34 | MP0004130_abnormal_muscle_cell | 1.25606414 |
| 35 | MP0003646_muscle_fatigue | 1.23521194 |
| 36 | MP0002078_abnormal_glucose_homeostasis | 1.18991187 |
| 37 | MP0001944_abnormal_pancreas_morphology | 1.18597136 |
| 38 | MP0009697_abnormal_copulation | 1.17798066 |
| 39 | MP0001661_extended_life_span | 1.15559074 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.15357449 |
| 41 | MP0000598_abnormal_liver_morphology | 1.08156764 |
| 42 | MP0003011_delayed_dark_adaptation | 1.02259109 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.01461232 |
| 44 | MP0003950_abnormal_plasma_membrane | 0.99363369 |
| 45 | MP0004147_increased_porphyrin_level | 0.98997189 |
| 46 | MP0003690_abnormal_glial_cell | 0.98637208 |
| 47 | MP0000751_myopathy | 0.98615032 |
| 48 | MP0005330_cardiomyopathy | 0.96688867 |
| 49 | MP0005165_increased_susceptibility_to | 0.94187058 |
| 50 | MP0000343_altered_response_to | 0.92340004 |
| 51 | MP0009053_abnormal_anal_canal | 0.90927853 |
| 52 | MP0003075_altered_response_to | 0.90839615 |
| 53 | MP0009642_abnormal_blood_homeostasis | 0.89650211 |
| 54 | MP0003879_abnormal_hair_cell | 0.88351917 |
| 55 | MP0000639_abnormal_adrenal_gland | 0.87670299 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 0.87489737 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 0.86836215 |
| 58 | MP0009763_increased_sensitivity_to | 0.86627451 |
| 59 | MP0008469_abnormal_protein_level | 0.86120562 |
| 60 | MP0009785_altered_susceptibility_to | 0.86068646 |
| 61 | MP0000604_amyloidosis | 0.85886676 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 0.85734002 |
| 63 | MP0001756_abnormal_urination | 0.84903042 |
| 64 | MP0002332_abnormal_exercise_endurance | 0.82996461 |
| 65 | MP0009765_abnormal_xenobiotic_induced | 0.81865790 |
| 66 | MP0005023_abnormal_wound_healing | 0.81561279 |
| 67 | MP0003329_amyloid_beta_deposits | 0.79595820 |
| 68 | MP0004264_abnormal_extraembryonic_tissu | 0.78856741 |
| 69 | MP0000747_muscle_weakness | 0.78658841 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.77518509 |
| 71 | MP0003436_decreased_susceptibility_to | 0.76404362 |
| 72 | MP0010155_abnormal_intestine_physiology | 0.75615300 |
| 73 | MP0002876_abnormal_thyroid_physiology | 0.75009251 |
| 74 | MP0000249_abnormal_blood_vessel | 0.73973617 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.73772560 |
| 76 | MP0005647_abnormal_sex_gland | 0.73752736 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.73472231 |
| 78 | MP0001533_abnormal_skeleton_physiology | 0.73183976 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.72960987 |
| 80 | MP0005166_decreased_susceptibility_to | 0.71710406 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 0.70976705 |
| 82 | MP0004036_abnormal_muscle_relaxation | 0.68413488 |
| 83 | MP0005266_abnormal_metabolism | 0.67600419 |
| 84 | MP0005535_abnormal_body_temperature | 0.64224977 |
| 85 | MP0003953_abnormal_hormone_level | 0.63851523 |
| 86 | MP0001845_abnormal_inflammatory_respons | 0.62683553 |
| 87 | MP0004510_myositis | 0.62249705 |
| 88 | MP0006082_CNS_inflammation | 0.61977859 |
| 89 | MP0000613_abnormal_salivary_gland | 0.61597161 |
| 90 | MP0004381_abnormal_hair_follicle | 0.61407670 |
| 91 | MP0008004_abnormal_stomach_pH | 0.61107332 |
| 92 | MP0005164_abnormal_response_to | 0.60747176 |
| 93 | MP0003705_abnormal_hypodermis_morpholog | 0.60433630 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.58872097 |
| 95 | MP0009115_abnormal_fat_cell | 0.57861043 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.57618775 |
| 97 | MP0000749_muscle_degeneration | 0.56931230 |
| 98 | MP0002168_other_aberrant_phenotype | 0.56898542 |
| 99 | MP0005334_abnormal_fat_pad | 0.56871019 |
| 100 | MP0002971_abnormal_brown_adipose | 0.55783987 |
| 101 | MP0000678_abnormal_parathyroid_gland | 0.55520362 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.55460179 |
| 103 | MP0000462_abnormal_digestive_system | 0.55044817 |
| 104 | MP0008874_decreased_physiological_sensi | 0.54612111 |
| 105 | MP0003724_increased_susceptibility_to | 0.54105852 |
| 106 | MP0000858_altered_metastatic_potential | 0.53622966 |
| 107 | MP0002419_abnormal_innate_immunity | 0.53089920 |
| 108 | MP0004233_abnormal_muscle_weight | 0.52106288 |
| 109 | MP0006035_abnormal_mitochondrial_morpho | 0.50253946 |
| 110 | MP0005025_abnormal_response_to | 0.49093717 |
| 111 | MP0008872_abnormal_physiological_respon | 0.49073799 |
| 112 | MP0001851_eye_inflammation | 0.48985525 |
| 113 | MP0003638_abnormal_response/metabolism_ | 0.48670189 |
| 114 | MP0009764_decreased_sensitivity_to | 0.48160145 |
| 115 | MP0002928_abnormal_bile_duct | 0.47717455 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.47690305 |
| 117 | MP0009672_abnormal_birth_weight | 0.47565227 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.47526110 |
| 119 | MP0008873_increased_physiological_sensi | 0.45998756 |
| 120 | MP0002132_abnormal_respiratory_system | 0.45654363 |
| 121 | MP0003718_maternal_effect | 0.45446454 |
| 122 | MP0000566_synostosis | 0.45359373 |
| 123 | MP0003959_abnormal_lean_body | 0.43820502 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.43760782 |
| 125 | MP0005448_abnormal_energy_balance | 0.42991023 |
| 126 | MP0004142_abnormal_muscle_tone | 0.42904452 |
| 127 | MP0005395_other_phenotype | 0.42404634 |
| 128 | MP0008260_abnormal_autophagy | 0.41738944 |
| 129 | MP0002229_neurodegeneration | 0.40074511 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.39915453 |
| 131 | MP0004885_abnormal_endolymph | 0.39870856 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.39055067 |
| 133 | MP0005670_abnormal_white_adipose | 0.37334636 |
| 134 | MP0000579_abnormal_nail_morphology | 0.37282838 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.37134194 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.37039581 |
| 137 | MP0003172_abnormal_lysosome_physiology | 0.37026337 |
| 138 | MP0003183_abnormal_peptide_metabolism | 0.36677768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.67989264 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.92456138 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 5.77119811 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.41203507 |
| 5 | Hypoglycemic coma (HP:0001325) | 5.27306933 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.10315747 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.66276602 |
| 8 | Xanthomatosis (HP:0000991) | 4.65337476 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.58538785 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.31542434 |
| 11 | Ketosis (HP:0001946) | 4.20389447 |
| 12 | Hypoglycemic seizures (HP:0002173) | 3.99558297 |
| 13 | Glomerulonephritis (HP:0000099) | 3.98896755 |
| 14 | Hyperammonemia (HP:0001987) | 3.96522882 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 3.88320403 |
| 16 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.83175255 |
| 17 | Hyperglycinemia (HP:0002154) | 3.81918658 |
| 18 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.78731797 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 3.76284676 |
| 20 | Fat malabsorption (HP:0002630) | 3.70601108 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.62442342 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.62442342 |
| 23 | Ketoacidosis (HP:0001993) | 3.58477772 |
| 24 | Joint hemorrhage (HP:0005261) | 3.58441852 |
| 25 | Generalized aminoaciduria (HP:0002909) | 3.58084226 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.57668852 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.51495250 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.43173624 |
| 29 | Purpura (HP:0000979) | 3.39940213 |
| 30 | Hyperglycinuria (HP:0003108) | 3.35828991 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.32897357 |
| 32 | Complement deficiency (HP:0004431) | 3.24358126 |
| 33 | Hypolipoproteinemia (HP:0010981) | 3.23910117 |
| 34 | Symptomatic seizures (HP:0011145) | 3.21478921 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 3.18208147 |
| 36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.18208147 |
| 37 | Nephritis (HP:0000123) | 3.18032226 |
| 38 | Steatorrhea (HP:0002570) | 3.15412328 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.13932744 |
| 40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.11660839 |
| 41 | Epidermoid cyst (HP:0200040) | 3.04486455 |
| 42 | Hyperbilirubinemia (HP:0002904) | 2.97689790 |
| 43 | Abnormality of proline metabolism (HP:0010907) | 2.97566926 |
| 44 | Hydroxyprolinuria (HP:0003080) | 2.97566926 |
| 45 | Gout (HP:0001997) | 2.92777349 |
| 46 | Spontaneous abortion (HP:0005268) | 2.89300349 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.79642404 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.79465205 |
| 49 | Lethargy (HP:0001254) | 2.75183816 |
| 50 | Hemorrhage of the eye (HP:0011885) | 2.73664988 |
| 51 | Hepatic necrosis (HP:0002605) | 2.69365184 |
| 52 | Metabolic acidosis (HP:0001942) | 2.69307339 |
| 53 | Late onset (HP:0003584) | 2.68005755 |
| 54 | Mitral stenosis (HP:0001718) | 2.64890598 |
| 55 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.63065180 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.61987833 |
| 57 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.61254738 |
| 58 | Cerebral edema (HP:0002181) | 2.61090151 |
| 59 | Hypoalphalipoproteinemia (HP:0003233) | 2.60307744 |
| 60 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.59703717 |
| 61 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.59703717 |
| 62 | Glycosuria (HP:0003076) | 2.56775414 |
| 63 | Abnormality of urine glucose concentration (HP:0011016) | 2.56775414 |
| 64 | Gingival bleeding (HP:0000225) | 2.55696239 |
| 65 | Abnormality of nucleobase metabolism (HP:0010932) | 2.55347739 |
| 66 | Menorrhagia (HP:0000132) | 2.54177179 |
| 67 | Abnormality of the Achilles tendon (HP:0005109) | 2.50339297 |
| 68 | Irritability (HP:0000737) | 2.49237135 |
| 69 | Brushfield spots (HP:0001088) | 2.47536994 |
| 70 | Opisthotonus (HP:0002179) | 2.46096754 |
| 71 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.42067549 |
| 72 | Increased serum ferritin (HP:0003281) | 2.40473736 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39916433 |
| 74 | Cerebral palsy (HP:0100021) | 2.38049582 |
| 75 | Vascular calcification (HP:0004934) | 2.37244031 |
| 76 | Dysostosis multiplex (HP:0000943) | 2.35444955 |
| 77 | Myocardial infarction (HP:0001658) | 2.33850201 |
| 78 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29753333 |
| 79 | Mucopolysacchariduria (HP:0008155) | 2.29753333 |
| 80 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.29618068 |
| 81 | Abnormality of alanine metabolism (HP:0010916) | 2.29618068 |
| 82 | Hyperalaninemia (HP:0003348) | 2.29618068 |
| 83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27666594 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27666594 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27666594 |
| 86 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27383489 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 2.22569555 |
| 88 | Hypercholesterolemia (HP:0003124) | 2.20611005 |
| 89 | Abnormal gallbladder morphology (HP:0012437) | 2.20215795 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20153457 |
| 91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20153457 |
| 92 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20153457 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 2.18970565 |
| 94 | Hyperglycemia (HP:0003074) | 2.18439403 |
| 95 | Abnormality of vitamin metabolism (HP:0100508) | 2.16315176 |
| 96 | Renal cortical cysts (HP:0000803) | 2.15812464 |
| 97 | Increased mean platelet volume (HP:0011877) | 2.14310190 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.11260926 |
| 99 | Vomiting (HP:0002013) | 2.11138078 |
| 100 | Pancreatitis (HP:0001733) | 2.10613993 |
| 101 | Proximal tubulopathy (HP:0000114) | 2.10056273 |
| 102 | Acute encephalopathy (HP:0006846) | 2.09990631 |
| 103 | Abnormality of complement system (HP:0005339) | 2.09418557 |
| 104 | Nausea (HP:0002018) | 2.08907029 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 2.07895704 |
| 106 | Rhabdomyolysis (HP:0003201) | 2.06801908 |
| 107 | Methylmalonic aciduria (HP:0012120) | 2.04899280 |
| 108 | Asymmetric septal hypertrophy (HP:0001670) | 2.04642181 |
| 109 | Epistaxis (HP:0000421) | 2.04379413 |
| 110 | Alkalosis (HP:0001948) | 2.02361744 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.01528328 |
| 112 | Spastic paraparesis (HP:0002313) | 2.00203182 |
| 113 | Hepatocellular carcinoma (HP:0001402) | 1.99390454 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 1.98773777 |
| 115 | Rickets (HP:0002748) | 1.97704242 |
| 116 | Acute hepatic failure (HP:0006554) | 1.97368004 |
| 117 | Atrioventricular block (HP:0001678) | 1.96464537 |
| 118 | Cardiovascular calcification (HP:0011915) | 1.95596614 |
| 119 | Epiphyseal stippling (HP:0010655) | 1.95098694 |
| 120 | Progressive neurologic deterioration (HP:0002344) | 1.93253503 |
| 121 | Renal Fanconi syndrome (HP:0001994) | 1.92660442 |
| 122 | Petechiae (HP:0000967) | 1.92389179 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.92025811 |
| 124 | Hepatocellular necrosis (HP:0001404) | 1.88258805 |
| 125 | Methylmalonic acidemia (HP:0002912) | 1.87326435 |
| 126 | Elevated alkaline phosphatase (HP:0003155) | 1.86821384 |
| 127 | Neurofibrillary tangles (HP:0002185) | 1.86619790 |
| 128 | Abnormal platelet volume (HP:0011876) | 1.86519862 |
| 129 | Abnormality of glycolysis (HP:0004366) | 1.86366953 |
| 130 | Increased serum pyruvate (HP:0003542) | 1.86366953 |
| 131 | Elevated hepatic transaminases (HP:0002910) | 1.85292716 |
| 132 | Cholelithiasis (HP:0001081) | 1.84332015 |
| 133 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.83861150 |
| 134 | Abnormal platelet function (HP:0011869) | 1.83821511 |
| 135 | Impaired platelet aggregation (HP:0003540) | 1.83821511 |
| 136 | Amyloidosis (HP:0011034) | 1.82517429 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82416235 |
| 138 | Hyperphosphaturia (HP:0003109) | 1.82321753 |
| 139 | Abnormal gallbladder physiology (HP:0012438) | 1.81170789 |
| 140 | Cholecystitis (HP:0001082) | 1.81170789 |
| 141 | Skin nodule (HP:0200036) | 1.80799897 |
| 142 | Increased purine levels (HP:0004368) | 1.80765643 |
| 143 | Hyperuricemia (HP:0002149) | 1.80765643 |
| 144 | Enlarged kidneys (HP:0000105) | 1.79942172 |
| 145 | Thrombophlebitis (HP:0004418) | 1.77952813 |
| 146 | Abnormal atrioventricular conduction (HP:0005150) | 1.77339947 |
| 147 | Decreased subcutaneous fat (HP:0001002) | 1.77026672 |
| 148 | Ileus (HP:0002595) | 1.76919338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.92979345 |
| 2 | INSRR | 4.23045545 |
| 3 | MAPK15 | 3.74219333 |
| 4 | MYLK | 3.55979999 |
| 5 | STK16 | 3.13344214 |
| 6 | STK39 | 3.12792147 |
| 7 | ERN1 | 3.12262187 |
| 8 | MAPKAPK3 | 2.98309136 |
| 9 | EPHB1 | 2.91981971 |
| 10 | ACVR1B | 2.70257984 |
| 11 | TAOK3 | 2.58576870 |
| 12 | FLT3 | 2.45174802 |
| 13 | WNK4 | 2.35323195 |
| 14 | TESK1 | 2.23528814 |
| 15 | OXSR1 | 2.15768846 |
| 16 | TRIB3 | 2.15060507 |
| 17 | PASK | 2.10396722 |
| 18 | TESK2 | 2.05597925 |
| 19 | PDK2 | 2.05006729 |
| 20 | EIF2AK3 | 2.03776970 |
| 21 | PBK | 2.02130309 |
| 22 | SCYL2 | 1.98182537 |
| 23 | PIK3CG | 1.97302684 |
| 24 | MET | 1.90020082 |
| 25 | OBSCN | 1.79991420 |
| 26 | RIPK1 | 1.69059126 |
| 27 | FGFR4 | 1.63408105 |
| 28 | SIK1 | 1.63298606 |
| 29 | TIE1 | 1.58472760 |
| 30 | TTN | 1.57966962 |
| 31 | MAPKAPK5 | 1.57575314 |
| 32 | LIMK1 | 1.53763149 |
| 33 | TGFBR2 | 1.53223096 |
| 34 | MAP3K3 | 1.45654822 |
| 35 | TAOK2 | 1.43293701 |
| 36 | CDK19 | 1.41876048 |
| 37 | CSNK1G1 | 1.34971378 |
| 38 | CSNK1G3 | 1.34677588 |
| 39 | EIF2AK1 | 1.24904815 |
| 40 | TLK1 | 1.23741554 |
| 41 | BCR | 1.19557884 |
| 42 | CSNK1A1L | 1.17486154 |
| 43 | HIPK2 | 1.16369024 |
| 44 | PIK3CA | 1.14307216 |
| 45 | ERBB4 | 1.09258768 |
| 46 | IKBKB | 1.08632408 |
| 47 | WNK3 | 1.06559657 |
| 48 | IRAK3 | 1.04110131 |
| 49 | PINK1 | 1.03226406 |
| 50 | LMTK2 | 1.00153014 |
| 51 | NME2 | 0.96362863 |
| 52 | DYRK1B | 0.96007289 |
| 53 | DDR2 | 0.95422385 |
| 54 | MAP3K14 | 0.95000959 |
| 55 | NLK | 0.92371874 |
| 56 | KDR | 0.91923775 |
| 57 | IRAK1 | 0.89729290 |
| 58 | UHMK1 | 0.88864860 |
| 59 | GRK7 | 0.87870340 |
| 60 | TEC | 0.87667664 |
| 61 | VRK1 | 0.86611028 |
| 62 | CAMK2G | 0.86241250 |
| 63 | MST4 | 0.85105472 |
| 64 | GRK6 | 0.85096809 |
| 65 | PTK6 | 0.85053319 |
| 66 | MAP2K2 | 0.84972018 |
| 67 | TRPM7 | 0.84262761 |
| 68 | ARAF | 0.83402842 |
| 69 | GRK1 | 0.81464585 |
| 70 | TNK2 | 0.80744535 |
| 71 | FER | 0.80199074 |
| 72 | BUB1 | 0.79170164 |
| 73 | GSK3A | 0.77594057 |
| 74 | ILK | 0.76606757 |
| 75 | CSNK1G2 | 0.76278405 |
| 76 | BTK | 0.75981223 |
| 77 | MAPK11 | 0.73224884 |
| 78 | ADRBK2 | 0.71256634 |
| 79 | DYRK3 | 0.71052388 |
| 80 | FGFR2 | 0.70946136 |
| 81 | DAPK3 | 0.70763094 |
| 82 | MAP3K6 | 0.69648472 |
| 83 | ABL2 | 0.69425207 |
| 84 | NTRK1 | 0.67588107 |
| 85 | CAMK2D | 0.66453217 |
| 86 | BLK | 0.66258289 |
| 87 | ZAP70 | 0.65247173 |
| 88 | CAMKK2 | 0.65183859 |
| 89 | ITK | 0.64798086 |
| 90 | TXK | 0.63864156 |
| 91 | PHKG1 | 0.63417438 |
| 92 | PHKG2 | 0.63417438 |
| 93 | CAMK2B | 0.62678855 |
| 94 | MAP2K1 | 0.61890297 |
| 95 | BRSK2 | 0.61390537 |
| 96 | IRAK2 | 0.61137441 |
| 97 | PKN1 | 0.61096097 |
| 98 | MUSK | 0.60950744 |
| 99 | TNIK | 0.59775789 |
| 100 | NEK9 | 0.59109904 |
| 101 | PAK4 | 0.56694294 |
| 102 | JAK2 | 0.53588049 |
| 103 | IGF1R | 0.51448683 |
| 104 | MST1R | 0.50318738 |
| 105 | RPS6KA5 | 0.49458367 |
| 106 | MAP3K12 | 0.48844120 |
| 107 | PRKG2 | 0.48626261 |
| 108 | LATS1 | 0.47786777 |
| 109 | AKT3 | 0.46174040 |
| 110 | DAPK1 | 0.45754371 |
| 111 | EPHA3 | 0.45251037 |
| 112 | CHUK | 0.44404399 |
| 113 | PRKD2 | 0.43793242 |
| 114 | CDC42BPA | 0.43685862 |
| 115 | WNK1 | 0.42971494 |
| 116 | KIT | 0.42943523 |
| 117 | PRKCQ | 0.42679693 |
| 118 | MAP3K5 | 0.42562326 |
| 119 | EPHA2 | 0.42003648 |
| 120 | JAK1 | 0.41823040 |
| 121 | PAK2 | 0.41767799 |
| 122 | SGK223 | 0.41337932 |
| 123 | SGK494 | 0.41337932 |
| 124 | ADRBK1 | 0.40565647 |
| 125 | MAPK12 | 0.40557043 |
| 126 | RPS6KB2 | 0.39616752 |
| 127 | MAP2K6 | 0.39332229 |
| 128 | TBK1 | 0.39291742 |
| 129 | TAOK1 | 0.38283468 |
| 130 | MAP2K3 | 0.37300328 |
| 131 | BMX | 0.36981178 |
| 132 | PRKACG | 0.36459428 |
| 133 | SMG1 | 0.35736964 |
| 134 | PDK1 | 0.35037032 |
| 135 | VRK2 | 0.34888378 |
| 136 | DYRK2 | 0.34558093 |
| 137 | FRK | 0.34482874 |
| 138 | AKT2 | 0.33797205 |
| 139 | STK38 | 0.33740220 |
| 140 | PIM2 | 0.32464720 |
| 141 | TYK2 | 0.31716898 |
| 142 | JAK3 | 0.31699234 |
| 143 | CSK | 0.30967305 |
| 144 | PRKD1 | 0.30857795 |
| 145 | PRKAA1 | 0.30450471 |
| 146 | PRKAA2 | 0.30445028 |
| 147 | NEK6 | 0.30353270 |
| 148 | MAP3K1 | 0.29753200 |
| 149 | PDPK1 | 0.28804406 |
| 150 | IRAK4 | 0.27738330 |
| 151 | CSNK1A1 | 0.27546461 |
| 152 | BRAF | 0.26518477 |
| 153 | PTK2 | 0.25154467 |
| 154 | BMPR2 | 0.24785233 |
| 155 | MAPK4 | 0.22426483 |
| 156 | MAP3K11 | 0.22223980 |
| 157 | NUAK1 | 0.21824670 |
| 158 | PRKACA | 0.21459906 |
| 159 | CSF1R | 0.21321201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.50189714 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.83093496 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.79827433 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73824311 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71053534 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.63682971 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.57519578 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.49119419 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.45685842 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36066853 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.30091226 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.28466964 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.27640479 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24754417 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18473510 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14300431 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.13554759 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13094530 |
| 19 | Protein export_Homo sapiens_hsa03060 | 2.06705746 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.98838689 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98810564 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.93266612 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91215967 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86906390 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83053436 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82611354 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.77732586 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.74795385 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72803342 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71211988 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69250307 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67418920 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56531727 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48409394 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48264203 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42386432 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.41359278 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32880293 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.32783157 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31221558 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29086289 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28168025 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28105668 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26942361 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24499807 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21405516 |
| 47 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19416165 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.16109195 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08998199 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07283285 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05656678 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04563614 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01370746 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01317555 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98647095 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96037515 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 0.93513514 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91602520 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87529245 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82824330 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80125026 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78007901 |
| 63 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.72656291 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72271546 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68476944 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67921249 |
| 67 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67114962 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65455566 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56025277 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51516327 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51195091 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46488157 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.45872534 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.45367913 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40255433 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39593727 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.38446420 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.37324550 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35989312 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33494216 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32269008 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29442713 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27839240 |
| 84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.26833895 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.26468853 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26323232 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.24233393 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23552394 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21884019 |
| 90 | Proteasome_Homo sapiens_hsa03050 | 0.20825097 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20319863 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.19688618 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19574246 |
| 94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.17787831 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15073155 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.11754371 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.09734072 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.06394127 |
| 99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.05409860 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.04972209 |
| 101 | Purine metabolism_Homo sapiens_hsa00230 | 0.04298367 |
| 102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.03033228 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.01818209 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.1182576 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1040232 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | -0.0699433 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0663968 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0550500 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0451781 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0404119 |
| 111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0351765 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0337032 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0335919 |
| 114 | Platelet activation_Homo sapiens_hsa04611 | -0.0205637 |
| 115 | Asthma_Homo sapiens_hsa05310 | -0.0052498 |

